Researchers Develop Guidelines for Evaluating Cognitive and Behavioral Syndromes in Adults

A Tool for Medical Professionals

According to the workgroup, a timely and accurate diagnosis of Alzheimer’s disease and related dementias increases patient autonomy when he or she is most able to participate in goals of treatment and life and care decisions. It also allows for early intervention to maximize support opportunities and treatment outcomes.

“These new guidelines will provide an important new tool for medical professionals to more accurately diagnose Alzheimer’s [disease] and other dementias. As a result, people will get the right care and appropriate treatments; families will get the right support and be able to plan for the future,” said James Hendrix, PhD, Alzheimer’s Association Director of Global Science Initiatives and a member of the workgroup. “Too often, cognitive and behavioral symptoms due to Alzheimer’s disease and other dementias are unrecognized or attributed to something else.”

“The guidelines can empower patients, families, and clinicians to expect that symptoms will be evaluated in a patient-centered, structured, and collaborative manner,” Dr. Atri said. “In addition, they help to ensure that, regardless of the specific diagnosis, the results are communicated in a timely and compassionate way to help patients and families live the best lives possible.”